1. Home
  2. COEP vs PXLW Comparison

COEP vs PXLW Comparison

Compare COEP & PXLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COEP
  • PXLW
  • Stock Information
  • Founded
  • COEP 2017
  • PXLW 1997
  • Country
  • COEP United States
  • PXLW United States
  • Employees
  • COEP N/A
  • PXLW N/A
  • Industry
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • PXLW Semiconductors
  • Sector
  • COEP Health Care
  • PXLW Technology
  • Exchange
  • COEP Nasdaq
  • PXLW Nasdaq
  • Market Cap
  • COEP 27.4M
  • PXLW 28.1M
  • IPO Year
  • COEP N/A
  • PXLW 2000
  • Fundamental
  • Price
  • COEP $9.14
  • PXLW $7.18
  • Analyst Decision
  • COEP
  • PXLW Strong Buy
  • Analyst Count
  • COEP 0
  • PXLW 2
  • Target Price
  • COEP N/A
  • PXLW $15.00
  • AVG Volume (30 Days)
  • COEP 34.5K
  • PXLW 81.4K
  • Earning Date
  • COEP 08-15-2025
  • PXLW 08-06-2025
  • Dividend Yield
  • COEP N/A
  • PXLW N/A
  • EPS Growth
  • COEP N/A
  • PXLW N/A
  • EPS
  • COEP N/A
  • PXLW N/A
  • Revenue
  • COEP $62,874.00
  • PXLW $34,246,000.00
  • Revenue This Year
  • COEP N/A
  • PXLW $5.21
  • Revenue Next Year
  • COEP N/A
  • PXLW $35.68
  • P/E Ratio
  • COEP N/A
  • PXLW N/A
  • Revenue Growth
  • COEP N/A
  • PXLW N/A
  • 52 Week Low
  • COEP $2.31
  • PXLW $4.67
  • 52 Week High
  • COEP $13.70
  • PXLW $14.16
  • Technical
  • Relative Strength Index (RSI)
  • COEP 59.60
  • PXLW 53.74
  • Support Level
  • COEP $7.25
  • PXLW $7.01
  • Resistance Level
  • COEP $8.86
  • PXLW $7.56
  • Average True Range (ATR)
  • COEP 0.69
  • PXLW 0.80
  • MACD
  • COEP 0.15
  • PXLW 0.01
  • Stochastic Oscillator
  • COEP 75.48
  • PXLW 39.42

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

About PXLW Pixelworks Inc.

Pixelworks Inc is a provider of visual processing semiconductor and software solutions that enable consistently high-quality and authentic viewing experiences in a wide variety of applications. The company defines its key target markets as Mobile (smartphone and tablet), Home and Enterprise (projectors, personal video recorders (PVR), and over-the-air (OTA) streaming devices), and Cinema (creation, remastering, and delivery of digital video content). The company operates in one segment: the design, development, marketing and sale of IC solutions for use in electronic display devices. The company generates its revenue from two broad product markets: the Mobile market and the Home and Enterprise market. The majority of the revenue is earned in Japan.

Share on Social Networks: